- Product Listings
- Compare Products
- Calculators
- Product Tours
- Expert Reviews
- Our Experts
- Company Directory
- About Beye
- Contact Us
Ⓒ 2024 Beye.com. All rights reserved.
This content is intended for health care professionals and providers only. The information contained on Beye.com, including text, graphics, images, and interactive activities, is for informational purposes only, and is not intended to be a substitute for professional medical advice. Beye LLC, via its Editors and Publisher, accepts no responsibility for any injury or damage to persons or property occasioned through the implementation of any ideas or use of any product described herein. Although great care is taken to ensure that all information is accurate, it is recommended that readers seek independent verification of advice on drugs and other product usage, surgical techniques and clinical processes prior to their use. References made in article may indicate usage of medical equipment or drugs at dosages, for periods of time, and in combination not included in the current prescribing information. Inclusion of advertising materials on the website thereof, does not constitute and representation or guarantee by Beye LLC of the quality of such products, or of the claims made.
Hydrus Microstent
IvantisHydrus Microstent is designed to be inserted into Schlemm canal to enable circumferential outflow and function like a scaffold to prevent collapse of the canal. The device is made from nitinol, a super-elastic, biocompatible alloy.
At-a-Glance
- Material: Nitinol and titanium oxide coating
- Unique design allows aqueous flow through both the inner lumen and frames of the scaffold
- Ensures dilation along 90 degrees of Schlemm canal
Related Products
Details
FDA
Yes
CE Mark
Not specified
Classification
Ab interno
Indication
Not specified
Mechanism of Action
Functions like a scaffold to prevent collapse of the canal and enables circumferential outflow of aqueous humor through lumen openings
Usage
Treatment of mild to moderate glaucoma at the time of cataract surgery in patients currently on hypotensive medication
Company Information
Contact the company for additional information, availability, or pricing:
Ivantis
ivantisinc.com38 Discovery Suite 150
Irvine, CA 92618
Trending in Glaucoma
Powered by:
On the Front Lines of MIGS
Andrew A. Kao, MD
MillennialEye, May/June '18
Glaucoma Research Highlights
MillennialEye, May/June '18
Davinder S. Grover, MD, MPH
Davinder S. Grover, MD, MPH
CRSToday, April 2018
Pseudophakic Bullous Keratopathy
CRSToday, April 2018
MIGS: A Crash Course
Constance O. Okeke, MD, MSCE
CollaborativeEye, Mar/Apr '18
MIGS: The New Glaucoma Paradigm
Robert S. Stutman, OD, MBA, FAAO
CollaborativeEye, Mar/Apr '18
Persistent LASIK Flap Interface Fluid After DSAEK Procedure
CRSToday, February 2018
MIGS Update
CRSToday, Sep 2016
Show More
